Fibrinogen receptors, primarily integrin αIIbβ3, are crucial for platelet aggregation and thrombus formation by binding fibrinogen and other adhesive proteins. These receptors are targets for antiplatelet drugs, which help prevent thrombosis-related conditions like heart attacks and strokes.